» Articles » PMID: 35481544

Mosaic Divergent Repeat Interruptions in XDP Influence Repeat Stability and Disease Onset

Abstract

While many genetic causes of movement disorders have been identified, modifiers of disease expression are largely unknown. X-linked dystonia-parkinsonism (XDP) is a neurodegenerative disease caused by a SINE-VNTR-Alu(AGAGGG)n retrotransposon insertion in TAF1, with a polymorphic (AGAGGG)n repeat. Repeat length and variants in MSH3 and PMS2 explain ∼65% of the variance in age at onset (AAO) in XDP. However, additional genetic modifiers are conceivably at play in XDP, such as repeat interruptions. Long-read nanopore sequencing of PCR amplicons from XDP patients (n = 202) was performed to assess potential repeat interruption and instability. Repeat-primed PCR and Cas9-mediated targeted enrichment confirmed the presence of identified divergent repeat motifs. In addition to the canonical pure SINE-VNTR-Alu-5'-(AGAGGG)n, we observed a mosaic of divergent repeat motifs that polarized at the beginning of the tract, where the divergent repeat interruptions varied in motif length by having one, two, or three nucleotides fewer than the hexameric motif, distinct from interruptions in other disease-associated repeats, which match the lengths of the canonical motifs. All divergent configurations occurred mosaically and in two investigated brain regions (basal ganglia, cerebellum) and in blood-derived DNA from the same patient. The most common divergent interruption was AGG [5'-SINE-VNTR-Alu(AGAGGG)2AGG(AGAGGG)n], similar to the pure tract, followed by AGGG [5'-SINE-VNTR-Alu(AGAGGG)2AGGG(AGAGGG)n], at median frequencies of 0.425 (IQR: 0.42-0.43) and 0.128 (IQR: 0.12-0.13), respectively. The mosaic AGG motif was not associated with repeat number (estimate = -3.8342, P = 0.869). The mosaic pure tract frequency was associated with repeat number (estimate = 45.32, P = 0.0441) but not AAO (estimate = -41.486, P = 0.378). Importantly, the mosaic frequency of the AGGG negatively correlated with repeat number after adjusting for age at sampling (estimate = -161.09, P = 3.44 × 10-5). When including the XDP-relevant MSH3/PMS2 modifier single nucleotide polymorphisms into the model, the mosaic AGGG frequency was associated with AAO (estimate = 155.1063, P = 0.047); however, the association dissipated after including the repeat number (estimate = -92.46430, P = 0.079). We reveal novel mosaic divergent repeat interruptions affecting both motif length and sequence (DRILS) of the canonical motif polarized within the SINE-VNTR-Alu(AGAGGG)n repeat. Our study illustrates: (i) the importance of somatic mosaic genotypes; (ii) the biological plausibility of multiple modifiers (both germline and somatic) that can have additive effects on repeat instability; and (iii) that these variations may remain undetected without assessment of single molecules.

Citing Articles

Triplex H-DNA structure: the long and winding road from the discovery to its role in human disease.

Hisey J, Masnovo C, Mirkin S NAR Mol Med. 2024; 1(4):ugae024.

PMID: 39723156 PMC: 11667243. DOI: 10.1093/narmme/ugae024.


Clinicodemographic and Genetic Modifier Correlation in an X-Linked Dystonia-Parkinsonism Cohort from Mindanao.

Doquenia M, Dy Closas A, Algodon S, Suarez-Uy R, Ng A, Laabs B Mov Disord Clin Pract. 2024; 11(12):1604-1608.

PMID: 39400991 PMC: 11647983. DOI: 10.1002/mdc3.14193.


Parkinson's Disease is Predominantly a Genetic Disease.

Lim S, Klein C J Parkinsons Dis. 2024; 14(3):467-482.

PMID: 38552119 PMC: 11091652. DOI: 10.3233/JPD-230376.


Neuroenergetic Changes in Patients with X-Linked Dystonia-Parkinsonism and Female Carriers.

Prasuhn J, Henkel J, Algodon S, Uter J, Rosales R, Klein C Mov Disord Clin Pract. 2024; 11(5):550-555.

PMID: 38404049 PMC: 11078482. DOI: 10.1002/mdc3.14001.


Genetic Testing for Parkinson's Disease and Movement Disorders in Less Privileged Areas: Barriers and Opportunities.

Tan A, Cornejo-Olivas M, Okubadejo N, Pal P, Saranza G, Saffie-Awad P Mov Disord Clin Pract. 2024; 11(1):14-20.

PMID: 38291851 PMC: 10828609. DOI: 10.1002/mdc3.13903.


References
1.
Deshmukh A, Caron M, Mohiuddin M, Lanni S, Panigrahi G, Khan M . FAN1 exo- not endo-nuclease pausing on disease-associated slipped-DNA repeats: A mechanism of repeat instability. Cell Rep. 2021; 37(10):110078. DOI: 10.1016/j.celrep.2021.110078. View

2.
Domingo A, Westenberger A, Lee L, Braenne I, Liu T, Vater I . New insights into the genetics of X-linked dystonia-parkinsonism (XDP, DYT3). Eur J Hum Genet. 2015; 23(10):1334-40. PMC: 4592086. DOI: 10.1038/ejhg.2014.292. View

3.
Matsuura T, Fang P, Pearson C, Jayakar P, Ashizawa T, Roa B . Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: repeat purity as a disease modifier?. Am J Hum Genet. 2005; 78(1):125-9. PMC: 1380209. DOI: 10.1086/498654. View

4.
Wenninger S, Cumming S, Gutschmidt K, Okkersen K, Jimenez-Moreno A, Daidj F . Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1. Neurol Genet. 2021; 7(2):e572. PMC: 8054967. DOI: 10.1212/NXG.0000000000000572. View

5.
Bragg D, Mangkalaphiban K, Vaine C, Kulkarni N, Shin D, Yadav R . Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in . Proc Natl Acad Sci U S A. 2017; 114(51):E11020-E11028. PMC: 5754783. DOI: 10.1073/pnas.1712526114. View